AU2001266229A1 - Hcn polypeptides and polynucleotides and their use in therapy - Google Patents

Hcn polypeptides and polynucleotides and their use in therapy

Info

Publication number
AU2001266229A1
AU2001266229A1 AU2001266229A AU6622901A AU2001266229A1 AU 2001266229 A1 AU2001266229 A1 AU 2001266229A1 AU 2001266229 A AU2001266229 A AU 2001266229A AU 6622901 A AU6622901 A AU 6622901A AU 2001266229 A1 AU2001266229 A1 AU 2001266229A1
Authority
AU
Australia
Prior art keywords
polynucleotides
therapy
hcn polypeptides
hcn
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266229A
Inventor
Stewart Bates
Ceri Davies
Isro Gloger
Paul Johannes Leonardus Maria Strijbos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016360A external-priority patent/GB0016360D0/en
Priority claimed from GB0026946A external-priority patent/GB0026946D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001266229A1 publication Critical patent/AU2001266229A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001266229A 2000-07-03 2001-07-03 Hcn polypeptides and polynucleotides and their use in therapy Abandoned AU2001266229A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0016360.0 2000-07-03
GB0016360A GB0016360D0 (en) 2000-07-03 2000-07-03 New use
GB0026946A GB0026946D0 (en) 2000-11-03 2000-11-03 Novel compounds
GB0026946.4 2000-11-03
PCT/GB2001/002959 WO2002002630A2 (en) 2000-07-03 2001-07-03 Hcn polypeptides and polynucleotides and their use in therapy

Publications (1)

Publication Number Publication Date
AU2001266229A1 true AU2001266229A1 (en) 2002-01-14

Family

ID=26244586

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266229A Abandoned AU2001266229A1 (en) 2000-07-03 2001-07-03 Hcn polypeptides and polynucleotides and their use in therapy

Country Status (4)

Country Link
US (1) US20040033943A1 (en)
EP (1) EP1309624A2 (en)
AU (1) AU2001266229A1 (en)
WO (1) WO2002002630A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1297136A2 (en) 2000-05-24 2003-04-02 Akzo Nobel N.V. Full length human hcn1 ih channel subunit and variants
CA2435292A1 (en) * 2001-01-23 2002-08-15 Merck & Co., Inc. Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1
AU2002305809B2 (en) * 2001-06-08 2007-12-06 Ortho-Mcneil Pharmaceutical, Inc. Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
EP1536020A1 (en) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Means and methods for optical determination of cAMP in vitro and in vivo
US8859273B2 (en) * 2003-12-24 2014-10-14 Medtronic, Inc. Methods of using HCN genes to treat cardiac arrhythmias
JP2009541333A (en) 2006-06-23 2009-11-26 クインテセンス バイオサイエンシーズ インコーポレーティッド Modified ribonuclease
US20080089874A1 (en) * 2006-09-28 2008-04-17 The Regents Of The University Of California Directed differentiation and maturation of stem cell-derived cardiomyocytes
US20100203575A1 (en) * 2007-09-11 2010-08-12 Inserm (Institut National De La Sante Et De La Recherche Medicale) In Vitro Beating Heart Model
EP2198010A4 (en) 2007-09-12 2010-10-06 Univ California Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
WO2013183985A1 (en) * 2012-06-05 2013-12-12 Erasmus University Medical Center Rotterdam Method of treating cognitive impairment and compounds for use therein
EP3021946A2 (en) * 2013-07-16 2016-05-25 Karakossian, Movses Hcn inhibitors affecting ganglion cell function and visual function
US10087436B2 (en) 2014-02-06 2018-10-02 The Regents Of The University Of California Electrophysiologically mature cardiomyocytes and methods for making same
US10358636B2 (en) 2014-05-14 2019-07-23 Stealth Biologics, Llc Deimmunized lysostaphin and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080773A (en) * 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
US6703485B2 (en) * 1997-12-23 2004-03-09 The Trustees Of Columbia University In The City Of New York Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
DE19806581A1 (en) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Ih ion channel sequences and their use

Also Published As

Publication number Publication date
EP1309624A2 (en) 2003-05-14
US20040033943A1 (en) 2004-02-19
WO2002002630A3 (en) 2002-10-24
WO2002002630A2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
IL144954A0 (en) Quinazolines and therapeutic use thereof
AU2001266229A1 (en) Hcn polypeptides and polynucleotides and their use in therapy
EP1578769A4 (en) Peptides and the use thereof in darkening the skin
AU2001265009A1 (en) Human polynucleotides and polypeptides encoded thereby
IL153568A (en) Novel polypeptides and polynucleotides
AU2868601A (en) Biaryl compounds, their preparation and their use in therapy
AU2001280608A1 (en) Human polynucleotides and polypeptides encoded thereby
GB0026134D0 (en) Peptides and their use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
ZA983740B (en) Novel amidine derivatives and their use in therapy
IL156863A0 (en) Polynucleotides and polypeptides and their use in metabolic disorders
AU2002246858A1 (en) Human kinases and polynucleotides encoding the same
AU2002213183A1 (en) Human kinases and polynucleotides encoding the same
IL156864A0 (en) Polynucleotides and polypeptides and their use in metabolic disorders
AU3264202A (en) Novel human kinases and polynucleotides encoding the same
GB0031021D0 (en) Polynucleotides and polypeptides
GB0017028D0 (en) Peptides and their therapeutic use
AU2002215312A1 (en) Human proteases and polynucleotides encoding the same
AU2001272919A1 (en) Lp120 polypeptides and therapeutic uses thereof
GB0026428D0 (en) Hydroimidazolone derivatives and their use in therapy
AU4726901A (en) Novel human proteins and polynucleotides encoding the same
AU2002228633A1 (en) Human kinases and polynucleotides encoding the same
AU2002314059A1 (en) Oxazolo-and furopyrimidines and their use in medicaments against tumors
GB0001926D0 (en) Biaryl compounds their preparation and their use in therapy
GB0130733D0 (en) Therapeutic compounds and their use in therapy